Authors:
FLIEDER DB
BRAMBILLA E
RUSH W
PRZYGODZKI R
FLEMING M
FREEDMAN A
TRAVIS W
CAPORASO N
GUINEE D
BENNETT W
JONES R
TRASTEK V
PAIROLERO P
TAZELAAR H
JETT J
MIDTHUN D
LIOTTA L
HARRIS CC
Citation: Db. Flieder et al., RB AND P16 EXPRESSION IN NONSMALL CELL LUNG-CANCER (NSCLC), Modern pathology, 11(1), 1998, pp. 173-173
Authors:
JUNG SH
LLOYD RV
RUSH WR
PRZYGODZKI R
CAPORASO N
FLEMING MV
BENNETT W
PAIROLERO P
TRASTEK V
JETT JR
LIOTTA LA
HARRIS CC
TAZELAAR HD
TRAVIS WD
Citation: Sh. Jung et al., IN-SITU HYBRIDIZATION (ISH) FOR TRANSFORMING-GROWTH-FACTOR (TGF)-BETA-1, (TGF)-BETA-3, AND TGF-RECEPTOR-II (RII) MESSENGER-RNA IN NONSMALL CELL LUNG-CARCINOMA (NSCLC), Modern pathology, 11(1), 1998, pp. 176-176
Authors:
FINKELSTEIN SD
PRZYGODZKI R
PRICOLO VE
BAKKER A
SWALSKY PA
BLAND KI
Citation: Sd. Finkelstein et al., SINGLE CRYPT TOPOGRAPHIC GENOTYPING FOR 5Q21 GENE LOSS IDENTIFIES PATIENTS WITH INHERITED POLYPOSIS AND THOSE AT HIGH-RISK FOR DEVELOPMENT OF COLORECTAL-CANCER, Laboratory investigation, 76(1), 1997, pp. 307-307
Authors:
BURKE L
FREEDMAN A
ELDEIRY W
BENNETT W
GUINEE D
RUSH W
PRZYGODZKI R
JONES R
BORKOWSKI A
CAPORASO N
FLEMING MV
TRAVIS W
COLBY T
TRASTEK V
PAIROLERO P
TAZELAAR H
MIDTHUN D
LIOTTA L
VOGELSTEIN B
HARRIS C
Citation: L. Burke et al., CYCLIN D1, P53 AND P21(WAF1 CIP1) EXPRESSION PREDICT SURVIVAL IN NONSMALL CELL LUNG-CANCER (NSCLC)/, Laboratory investigation, 76(1), 1997, pp. 946-946
Authors:
FLEMING M
BRAMBILLA E
GAL A
FALK R
WEI M
ABBONDANZO S
PRZYGODZKI R
FINKELSTEIN S
RUSH W
KOSS M
TRAVIS W
Citation: M. Fleming et al., BCL-2 BAX RATIO (BBR) IN NEUROENDOCRINE LUNG-TUMORS (NET) PREDICTS POOR-PROGNOSIS AND P53 ABNORMALITIES/, Laboratory investigation, 76(1), 1997, pp. 959-959
Authors:
FLEMING M
BRAMBILLA E
FREEDMAN A
PRZYGODZKI R
CAPORASO N
BENNETT W
TRAVIS W
COLBY T
JETT J
TAZELAAR H
TRASTEK V
PAIROLERO P
LIOTTA L
HARRIS C
Citation: M. Fleming et al., BAX IMMUNOHISTOCHEMICAL STAINING (IHC) RELATES TO GENDER, GRADE, HISTOLOGY, FAMILY HISTORY, AND K-RAS MUTATIONS IN NONSMALL CELL CARCINOMAS(NSCC) OF THE LUNG, Laboratory investigation, 76(1), 1997, pp. 960-960
Authors:
WASELENKO JK
PRZYGODZKI R
GREVER MR
SHINN CA
SAUSVILLE E
BYRD JC
Citation: Jk. Waselenko et al., FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION, Blood, 90(10), 1997, pp. 2369-2369
Authors:
FINKELSTEIN SD
PRZYGODZKI R
PRICOLO VE
BAKKER A
SWALSKY PA
BLAND KI
Citation: Sd. Finkelstein et al., PREDICTIVE VALUE OF K-RAS-2 P53 POINT MUTATIONAL GENOTYPING IN DUKES-B AND DUKES-C COLONIC ADENOCARCINOMA/, Laboratory investigation, 74(1), 1996, pp. 320-320
Authors:
FLEMING MV
FALK R
PRZYGODZKI R
ZHANG J
BENNETT WP
TRAVIS WD
COLBY TV
JETT J
TAZELAAR H
TRASTEK V
PAIROLERO P
LIOTTA LA
CAPORASO NE
FERRANS VJ
HARRIS CC
Citation: Mv. Fleming et al., GENDER, AGE, AND ENVIRONMENTAL EXPOSURES ARE ASSOCIATED WITH INCREASED APOPTOSIS IN NON-SMALL-CELL (NSC) LUNG CARCINOMAS, Laboratory investigation, 74(1), 1996, pp. 904-904
Authors:
RUSH WL
ANDRIKO J
PRZYGODZKI R
FLEMING M
NELSON A
ABBONDANZO S
KOSS M
TRAVIS W
Citation: Wl. Rush et al., PRIMARY PULMONARY ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) - A CLINICOPATHOLOGICAL STUDY OF 6 CASES, Laboratory investigation, 74(1), 1996, pp. 951-951
Authors:
FINKELSTEIN SD
PRZYGODZKI R
BALLESTEROS E
PAULINO A
SAYEGH R
BAKKER A
SWALSKY PA
Citation: Sd. Finkelstein et al., COMPARISON OF P53 IMMUNOSTAINING AND POINT MUTATION DETERMINATION (PCR DIRECT SEQUENCING) IN FIXATIVE TREATED SPECIMENS OF SOLID TUMORS/, Laboratory investigation, 70(1), 1994, pp. 10000060-10000060
Authors:
PRZYGODZKI R
FINKELSTEIN S
ZEREN H
GUINEE D
GAL AA
FISHBACK N
MORAN C
MCCARTHY WF
KOSS M
TRAVIS W
Citation: R. Przygodzki et al., P53 ANALYSIS OF NEUROENDOCRINE (NE) TUMORS - DISCRIMINATING FACTORS IN ATYPICAL CARCINOID (AC) WITHIN THE NE SPECTRUM, Laboratory investigation, 70(1), 1994, pp. 10000153-10000153